February 6, 2019
Via: ForbesThe Trump Justice Department, following a tougher policy toward dubious False Claims Act lawsuits by private citizens, has moved to dismiss a pair of lawsuits by a former hedge-fund manager who shorted stock in pharmaceutical companies he accused of a […]
December 8, 2016
Via: ForbesThe post-election rebound in biotech and healthcare stocks has been running out of gas lately. On Wednesday it hit a wall. Time published its Person of the Year cover story on President-Elect Donald Trump Wednesday morning, and it took just […]